IL-18 underexpression reduces IL-2 levels during HIV infection: a critical step towards the faulty cell-mediated immunity?
Denis David(Institut Pasteur), Jean‐Luc Guesdon(Institut Pasteur), Marie-Pierre Treilhou(Institut Pasteur), Marcel Joussemet(Institut Pasteur), D. Chevrier(Institut Pasteur), B. Dupont(Délégation Paris 5), Jacques Thèze(Ventura County Community College District)
Cited by 8
Related Papers
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
|Clinical Microbiology and Infection|2011|752
Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
|Clinical Infectious Diseases|2003|680
Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
|Clinical Infectious Diseases|2008|469
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children
|The Pediatric Infectious Disease Journal|2002|436